A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Material Elimination
Based on the social media company, the service has taken down violative material and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.
After moments of joining one community, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Inside these communities, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has previously seen individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to possibly serious medical dangers”.
